Genomic Vision unveils TeloSizer® for precise cellular health analysis

Genomic Vision, a molecular diagnostics and technology company that develops tools and services focused on examining and controlling changes in the genome, has recently announced the unveiling of TeloSizer®, an advanced solution that will aid in enhancing the offerings of the firm in the telomere biology field and cellular health analysis.

TeloSizer® is based on Genomic Vision's patented molecular combing technology and FiberSmart®, its early access tool that identifies, captures pictures, and measures telomere length on single DNA molecules.

Telomeres are DNA-binding structures located at the ends of chromosomes that prevent DNA from being lost during DNA replication.

Shrinking of telomere is a natural process that contributes to cell senescence and aging in humans. Unprogrammed telomere lengthening has been linked to the beginning of numerous illnesses, including cancer.

In recent years, the Health Adjusted Life Expectancy (HALE) has aided in creating a $2 billion worldwide cellular health screening market.

A part of the cellular health industry is focused on understanding how telomere length may be detected as a biomarker in cell aging and illnesses such as cancer, neurological diseases, and other telomeropathies.

As per Dominique Remy-Renou, CEO of Genomic Vision, ‘TeloSizer® would assist in accelerating the development of innovative solutions that meet unfulfilled requirements in the healthcare, pharmaceutical, and biotechnology industries’.

‘TeloSizer® makes it possible to discover novel telomere length biomarkers or, perhaps more significantly, to validate current telomere length biomarkers’.

Sources cite that the addition of TeloSizer® to Genomic Vision’s service offering and the utility of molecular combing is a significant step forward.

TeloSizer® will serve in a new application area that combines with the current market products such as structural variation analysis, DNA replication analysis, and copy number variation.

It further demonstrates how Genomic Vision is offering exclusive products and services for the classification of genome preservation, a crucial set of conditions that will be needed for forthcoming work in cellular health and personalized medicine.

Source Credit - https://www.businesswire.com/news/home/20210928005870/en/Genomic-Vision-Launches-TeloSizer%C2%AE-for-Precise-Detection-and-Quantitative-Measurement-of-Telomere-Length